Production (Stage)
Cabaletta Bio, Inc.
CABA
$1.86
-$0.075-3.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -43.50% | -56.02% | -86.22% | -90.53% | -57.99% |
| Total Depreciation and Amortization | 23.41% | 39.29% | 19.44% | 15.14% | 7.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 60.61% | 77.55% | 137.47% | 101.38% | 58.65% |
| Change in Net Operating Assets | 26.22% | 339.45% | 428.83% | 96.77% | -2,808.45% |
| Cash from Operations | -28.41% | -40.58% | -61.24% | -74.86% | -90.26% |
| Capital Expenditure | 3.33% | -103.24% | -289.23% | -1,250.88% | -113.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 846.25% | -- | 150.95% | -- |
| Cash from Investing | 3.33% | 967.25% | 18,941.54% | 149.29% | -103.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -94.34% | -27.55% | -99.60% | 1,396.72% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -108.05% | -95.30% | -27.55% | -99.60% | 2,933.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.06% | -108.55% | 36.32% | -90.30% | -246.63% |